INmune Bio

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell INmune Bio and other ETFs, options, and stocks.

About INMB

INmune Bio, Inc. is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprogram the immune system to fight cancer and Alzheimer’s disease. Its product pipeline includes INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer and TRD, and LIVNate. 

CEO
Raymond J. Tesi
CEORaymond J. Tesi
Employees
22
Employees22
Headquarters
Boca Raton, Florida
HeadquartersBoca Raton, Florida
Founded
2015
Founded2015
Employees
22
Employees22

INMB Key Statistics

Market cap
74.04M
Market cap74.04M
Price-Earnings ratio
-1.43
Price-Earnings ratio-1.43
Dividend yield
Dividend yield
Average volume
2.05M
Average volume2.05M
High today
$3.00
High today$3.00
Low today
$2.76
Low today$2.76
Open price
$2.88
Open price$2.88
Volume
1.58M
Volume1.58M
52 Week high
$11.64
52 Week high$11.64
52 Week low
$1.89
52 Week low$1.89

Analyst ratings

43%

of 7 ratings
Buy
42.9%
Hold
42.9%
Sell
14.3%

People also own

Based on the portfolios of people who own INMB. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.